Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Completes Acquisition of Varian Product Lines

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said after the close of the market Wednesday that it has completed the acquisition of three product lines from Varian, which was acquired by Agilent last week.

The product lines include Varian's global inductively coupled plasma mass spectrometry instruments business; its global laboratory gas chromatography instruments business; and its global gas chromatography triple-quadrupole mass spectrometry instruments business. As part of the deal between Agilent and Bruker, the firms entered into a transitional services and supply agreement to facilitate uninterrupted delivery of the products and services associated with the product lines.

Bruker signed the deal to acquire the product lines in March.

The sale was a condition of regulatory clearance by European Union authorities of Agilent's $1.5 billion bid to acquire Varian.

"This acquisition offers an opportunity to leverage our existing technology, applications and customer support strengths in scientific instruments," Bruker President and CEO Frank Laukien said in a statement. "The three new product lines perfectly complement our existing mass spectrometry products, and will further strengthen Bruker's position in many industrial and applied markets with an expanded portfolio."

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.